These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 4806444)
1. [Effect of short-term treatment with chlorophenoxyisobutyrate on serum lipids and pseudocholinesterase and plasmatic fibrinogen in hyperlipemic patients]. Hărăguş S; Uza G; Opincaru A; Cucuianu M Stud Cercet Med Interna; 1973; 14(1):33-9. PubMed ID: 4806444 [No Abstract] [Full Text] [Related]
2. [Hyperlipemic conditions: results of their treatment with clofibrate-methandrostenolone]. Ciammaichella A; Torcia L Boll Soc Ital Cardiol; 1971; 16(12):841-51. PubMed ID: 5150179 [No Abstract] [Full Text] [Related]
3. [Changes in the spectrum of serum lipids following 3 months administration of clofibrate Spofa]. Cagánova A; Cagan S Cesk Farm; 1971 Nov; 20(9):341-6. PubMed ID: 5136172 [No Abstract] [Full Text] [Related]
4. Comparative hypolipidaemic effectiveness of gum guggulu (Commiphora mukul) fraction 'A', ethyl-P-chlorophenoxyisobutyrate and Ciba-13437-Su. Malhotra SC; Ahuja MM Indian J Med Res; 1971 Oct; 59(10):1621-32. PubMed ID: 5159000 [No Abstract] [Full Text] [Related]
5. Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. Arora RC; Arora S Atherosclerosis; 1981 Jul; 39(4):447-52. PubMed ID: 7259824 [TBL] [Abstract][Full Text] [Related]
6. [Influence of the change in the dose of Clofibrate Spofa and interruption of treatment on the lipid level of blood serum in persons with hyperlipemia]. Cagánová A; Cagán S Bratisl Lek Listy; 1972 Jul; 58(1):66-78. PubMed ID: 5077942 [No Abstract] [Full Text] [Related]
7. Serum pseudocholinesterase activity during experimental fattening. Popescu TA; Fekete T; Popescu E; Böjthy I; Laszlo M Med Interne; 1976; 14(1):71-3. PubMed ID: 946698 [TBL] [Abstract][Full Text] [Related]
8. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats]. Maroto ML; Priego JG; Piña M; Catalán RE Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396 [No Abstract] [Full Text] [Related]
10. [Serum pseudocholinesterase activity during intravenous procaine anesthesia]. Shi WZ Zhonghua Wai Ke Za Zhi; 1983 Nov; 21(11):670-5. PubMed ID: 6676013 [No Abstract] [Full Text] [Related]
11. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients]. Gniwotta E; Herter B ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162 [No Abstract] [Full Text] [Related]
12. [Effects on the serum lipids of bis (hydroxy-2 ethylthio) 1,10 decane (LL 1558) and clofibrate, based on 91 cases of primary hyperlipoproteinemia]. Rouffy J Sem Hop Ther; 1973 Jan; 49(1):31-6. PubMed ID: 4712022 [No Abstract] [Full Text] [Related]
13. Serum pseudocholinesterase in state anxiety. Modai I; Mendelsohn E; Schwartz B J Clin Psychiatry; 1987 May; 48(5):204-6. PubMed ID: 3571175 [TBL] [Abstract][Full Text] [Related]
14. [Monitoring of serum pseudocholinesterase and transferrin in intensive care patients]. Cantoni A; Pizzola A Minerva Anestesiol; 1986; 52(1-2):51-7. PubMed ID: 3736913 [No Abstract] [Full Text] [Related]
16. Effect of tobramycin on serum pseudocholinesterase levels. Paradelis AG; Balamoutsos NG; Anastassiadou G; Veggou H Methods Find Exp Clin Pharmacol; 1982; 4(2):121-3. PubMed ID: 7121122 [TBL] [Abstract][Full Text] [Related]
17. Serum pseudocholinesterase estimation in the management of organophosphate poisoning cases and the effect of PAM on regenerating it. Saravanapavananthan T Singapore Med J; 1987 Apr; 28(2):166-71. PubMed ID: 3629272 [No Abstract] [Full Text] [Related]
18. Serum pseudocholinesterase levels in the patients of coronary artery disease & their 'normal' first degree relatives. Tripathi AK; Sikka KK; Srivastava DK Indian Heart J; 1987; 39(1):9-11. PubMed ID: 3450576 [No Abstract] [Full Text] [Related]